ABVC BioPharma (ABVC) Approved for ABV-1505 Phase II Part II in Taiwan Sites

Gentleman, Start Your Engines? ABVC BioPharma Receives Taiwan Regulatory Approval for ABV-1505 ADHD Phase II Part 2 Clinical Study
candida auris, citius pharma, biotech stock review

Citius Pharma’s (CTXR) Mino-Lok® Highly Efficacious in Rapidly Eradicating Candida auris.

CRANFORD, N.J., May 13, 2019 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius") (Nasdaq: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug...
SEKER, INTERNETSTOCKREVIEW

NYC Woman says she Lost Over $740K After her Lawyer’s Email was Hacked

NY POST Published Aug. 26, 2023, 10:37 a.m. ET An Upper West Side woman lost the bulk of her...

Citius Pharma (CTXR) to Merge Subsidiary, with Publicly Traded SPAC TenX Keane (TENK). Shares...

We Would Define This as Huge News.. Citius Pharma would receive 67.5...
Biotech Stock Review. Citius, CTXR

More Great News From Citius Pharma (CTXR).

UPDATED CHART 6-15-21 Mino-Lok® Phase III, FDA NewsRussell 2000 Index NewsTechnical Breakout News

Iconic Brands (ICNB) Reports Revenues of $13.8 Million vs $4 Million. Bounces 40% Intraday.

After a Rough Six Months in the market, Nine Month Numbers Propels the Stock 40% Higher Signaling Possible Bottoming Process. ...
Biotech Stock Review

True Nature (TNTY) Mitesco Set to Launch Mitesco PLC Incubator — Aligns With Matheson...

Hires Legal Powerhouse Matheson as Counsel and Advisor on its European Acquisitions Efforts. Established...

Adding Society Pass (SOPA) $0.96 to the Watch List

Amazing Fast Grower, in the Asian Silicon Valley. After a wildly successful IPO debut and subsequent tumble, Society...

ARK vs. SARK

Ever get really, really bearish and really, really wish you could find a simple way to make money in a bear market?
Cyclerion CYCN, Biotech Stock Review

Adding Cyclerion Thera (CYCN) $3.75, to Biotech Stock Review Watch List.

From the Tiki Hut Fund Cyclerion Therapeutics Inc (CYCN) | And We Have Deal, Up 30%. LIVE...

Latest article

Ardelyx (ARDX) Reports First Quarter 2024 Showing $204 Million in Cash!

When we added Ardelyx (ARDX) to the Watch List in November of 2022, the market cap near $80 million. Now it's...

GeoVax to Provide Corporate Update on Tuesday May 14, 2024.

Still our favorite biotech microcap, still our favorite management team, and our favorite risk to reward idea with a $4 million market...

NovaVax (NVAX) Roars Higher, Gaining 225% a $1.2 Billion Increase, at the Blink of...

Sanofi (SNY) Announces Partnership - $500 Million Upfront, plus $700 million in Milestones with NovaVax (NVAX). And some investors say Covid is...